 | • レポートコード：QYR9ST04909 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、炎症性腸疾患の世界市場について調査・分析し、炎症性腸疾患の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（クローン病、潰瘍性大腸炎 ）、用途別（治療、診断）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の炎症性腸疾患市場動向 ・主要企業別マーケットシェア ・炎症性腸疾患の種類別市場規模2014-2019 （クローン病、潰瘍性大腸炎 ） ・炎症性腸疾患の用途別市場規模2014-2019 （治療、診断） ・炎症性腸疾患の北米市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患の中国市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患の日本国内市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患の東南アジア市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患のインド市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol-Myers Squibb Company、Baxter International、Johnson & Johnson、Sanofi-Aventis、Abbott Laboratories、Pluristem Therapeutics、Pfizer、AstraZeneca、Cephalon、Amgen） ・炎症性腸疾患の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn’s diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn’s disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.Medical treatment of IBD is individualised to each patient. The choice of which drugs to use and by which route to administer them (oral, rectal, injection, infusion) depends on factors including the type, distribution, and severity of the patient’s disease, as well as other historical and biochemical prognostic factors, and patient preferences. For example, mesalazine is more useful in ulcerative colitis than in Crohn’s disease. Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms, with drugs such as prednisone, TNF inhibitors, azathioprine (Imuran), methotrexate, or 6-mercaptopurine.
In 2018, the global Inflammatory Bowel Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Inflammatory Bowel Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Bowel Disease development in United States, Europe and China.
The key players covered in this study
Bristol-Myers Squibb Company
Baxter International
Johnson & Johnson
Sanofi-Aventis
Abbott Laboratories
Pluristem Therapeutics
Pfizer
AstraZeneca
Cephalon
Amgen
Market segment by Type, the product can be split into
Crohns disease
Ulcerative colitis
Market segment by Application, split into
Therapeutic
Diagnostics
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Inflammatory Bowel Disease status, future forecast, growth opportunity, key market and key players.
To present the Inflammatory Bowel Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Inflammatory Bowel Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Inflammatory Bowel Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Crohns disease
1.4.3 Ulcerative colitis
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease Market Share by Application (2014-2025)
1.5.2 Therapeutic
1.5.3 Diagnostics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Inflammatory Bowel Disease Market Size
2.2 Inflammatory Bowel Disease Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease Market Size by Regions (2014-2025)
2.2.2 Inflammatory Bowel Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Inflammatory Bowel Disease Market Size by Manufacturers
3.1.1 Global Inflammatory Bowel Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Inflammatory Bowel Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Inflammatory Bowel Disease Market Concentration Ratio (CR5 and HHI)
3.2 Inflammatory Bowel Disease Key Players Head office and Area Served
3.3 Key Players Inflammatory Bowel Disease Product/Solution/Service
3.4 Date of Enter into Inflammatory Bowel Disease Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Inflammatory Bowel Disease Market Size by Type (2014-2019)
4.2 Global Inflammatory Bowel Disease Market Size by Application (2014-2019)
5 United States
5.1 United States Inflammatory Bowel Disease Market Size (2014-2019)
5.2 Inflammatory Bowel Disease Key Players in United States
5.3 United States Inflammatory Bowel Disease Market Size by Type
5.4 United States Inflammatory Bowel Disease Market Size by Application
6 Europe
6.1 Europe Inflammatory Bowel Disease Market Size (2014-2019)
6.2 Inflammatory Bowel Disease Key Players in Europe
6.3 Europe Inflammatory Bowel Disease Market Size by Type
6.4 Europe Inflammatory Bowel Disease Market Size by Application
7 China
7.1 China Inflammatory Bowel Disease Market Size (2014-2019)
7.2 Inflammatory Bowel Disease Key Players in China
7.3 China Inflammatory Bowel Disease Market Size by Type
7.4 China Inflammatory Bowel Disease Market Size by Application
8 Japan
8.1 Japan Inflammatory Bowel Disease Market Size (2014-2019)
8.2 Inflammatory Bowel Disease Key Players in Japan
8.3 Japan Inflammatory Bowel Disease Market Size by Type
8.4 Japan Inflammatory Bowel Disease Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Inflammatory Bowel Disease Market Size (2014-2019)
9.2 Inflammatory Bowel Disease Key Players in Southeast Asia
9.3 Southeast Asia Inflammatory Bowel Disease Market Size by Type
9.4 Southeast Asia Inflammatory Bowel Disease Market Size by Application
10 India
10.1 India Inflammatory Bowel Disease Market Size (2014-2019)
10.2 Inflammatory Bowel Disease Key Players in India
10.3 India Inflammatory Bowel Disease Market Size by Type
10.4 India Inflammatory Bowel Disease Market Size by Application
11 Central & South America
11.1 Central & South America Inflammatory Bowel Disease Market Size (2014-2019)
11.2 Inflammatory Bowel Disease Key Players in Central & South America
11.3 Central & South America Inflammatory Bowel Disease Market Size by Type
11.4 Central & South America Inflammatory Bowel Disease Market Size by Application
12 International Players Profiles
12.1 Bristol-Myers Squibb Company
12.1.1 Bristol-Myers Squibb Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Inflammatory Bowel Disease Introduction
12.1.4 Bristol-Myers Squibb Company Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.1.5 Bristol-Myers Squibb Company Recent Development
12.2 Baxter International
12.2.1 Baxter International Company Details
12.2.2 Company Description and Business Overview
12.2.3 Inflammatory Bowel Disease Introduction
12.2.4 Baxter International Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.2.5 Baxter International Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Inflammatory Bowel Disease Introduction
12.3.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Sanofi-Aventis
12.4.1 Sanofi-Aventis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Inflammatory Bowel Disease Introduction
12.4.4 Sanofi-Aventis Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.4.5 Sanofi-Aventis Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Inflammatory Bowel Disease Introduction
12.5.4 Abbott Laboratories Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.5.5 Abbott Laboratories Recent Development
12.6 Pluristem Therapeutics
12.6.1 Pluristem Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Inflammatory Bowel Disease Introduction
12.6.4 Pluristem Therapeutics Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.6.5 Pluristem Therapeutics Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Inflammatory Bowel Disease Introduction
12.7.4 Pfizer Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Inflammatory Bowel Disease Introduction
12.8.4 AstraZeneca Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Cephalon
12.9.1 Cephalon Company Details
12.9.2 Company Description and Business Overview
12.9.3 Inflammatory Bowel Disease Introduction
12.9.4 Cephalon Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.9.5 Cephalon Recent Development
12.10 Amgen
12.10.1 Amgen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Inflammatory Bowel Disease Introduction
12.10.4 Amgen Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.10.5 Amgen Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Inflammatory Bowel Disease Key Market Segments
Table Key Players Inflammatory Bowel Disease Covered
Table Global Inflammatory Bowel Disease Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Inflammatory Bowel Disease Market Size Market Share by Type 2014-2025
Figure Crohns disease Figures
Table Key Players of Crohns disease
Figure Ulcerative colitis Figures
Table Key Players of Ulcerative colitis
Table Global Inflammatory Bowel Disease Market Size Growth by Application 2014-2025 (Million US$)
Figure Therapeutic Case Studies
Figure Diagnostics Case Studies
Figure Inflammatory Bowel Disease Report Years Considered
Table Global Inflammatory Bowel Disease Market Size 2014-2025 (Million US$)
Figure Global Inflammatory Bowel Disease Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Inflammatory Bowel Disease Market Size by Regions 2014-2025 (Million US$)
Table Global Inflammatory Bowel Disease Market Size by Regions 2014-2019 (Million US$)
Table Global Inflammatory Bowel Disease Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease Market Share by Regions 2019
Table Market Top Trends
Table Global Inflammatory Bowel Disease Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease Market Share by Manufacturers (2014-2019)
Figure Global Inflammatory Bowel Disease Market Share by Manufacturers in 2018
Table Global Inflammatory Bowel Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Inflammatory Bowel Disease Product/Solution/Service
Table Date of Enter into Inflammatory Bowel Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Inflammatory Bowel Disease Market Size by Type (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease Market Size Share by Type (2014-2019)
Figure Global Inflammatory Bowel Disease Market Size Market Share by Type (2014-2019)
Table Global Inflammatory Bowel Disease Market Size by Application (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease Market Size Share by Application (2014-2019)
Figure Global Inflammatory Bowel Disease Market Size Market Share by Application (2014-2019)
Figure Global Inflammatory Bowel Disease Revenue Market Share by Application in 2018
Figure United States Inflammatory Bowel Disease Market Size 2014-2019 (Million US$)
Table United States Key Players Inflammatory Bowel Disease Revenue (2018-2019) (Million US$)
Table United States Key Players Inflammatory Bowel Disease Market Share (2018-2019)
Table United States Inflammatory Bowel Disease Market Size by Type (2014-2019) (Million US$)
Table United States Inflammatory Bowel Disease Market Share by Type (2014-2019)
Table United States Inflammatory Bowel Disease Market Size by Application (2014-2019) (Million US$)
Table United States Inflammatory Bowel Disease Market Share by Application (2014-2019)
Figure Europe Inflammatory Bowel Disease Market Size 2014-2019 (Million US$)
Table Europe Key Players Inflammatory Bowel Disease Revenue (2018-2019) (Million US$)
Table Europe Key Players Inflammatory Bowel Disease Market Share (2018-2019)
Table Europe Inflammatory Bowel Disease Market Size by Type (2014-2019) (Million US$)
Table Europe Inflammatory Bowel Disease Market Share by Type (2014-2019)
Table Europe Inflammatory Bowel Disease Market Size by Application (2014-2019) (Million US$)
Table Europe Inflammatory Bowel Disease Market Share by Application (2014-2019)
Figure China Inflammatory Bowel Disease Market Size 2014-2019 (Million US$)
Table China Key Players Inflammatory Bowel Disease Revenue (2018-2019) (Million US$)
Table China Key Players Inflammatory Bowel Disease Market Share (2018-2019)
Table China Inflammatory Bowel Disease Market Size by Type (2014-20189) (Million US$)
Table China Inflammatory Bowel Disease Market Share by Type (2014-2019)
Table China Inflammatory Bowel Disease Market Size by Application (2014-2019) (Million US$)
Table China Inflammatory Bowel Disease Market Share by Application (2014-2019)
Figure Japan Inflammatory Bowel Disease Market Size 2014-2019 (Million US$)
Table Japan Key Players Inflammatory Bowel Disease Revenue (2018-2019) (Million US$)
Table Japan Key Players Inflammatory Bowel Disease Market Share (2018-2019)
Table Japan Inflammatory Bowel Disease Market Size by Type (2014-2019) (Million US$)
Table Japan Inflammatory Bowel Disease Market Share by Type (2014-2019)
Table Japan Inflammatory Bowel Disease Market Size by Application (2014-2019) (Million US$)
Table Japan Inflammatory Bowel Disease Market Share by Application (2014-2019)
Figure Southeast Asia Inflammatory Bowel Disease Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Inflammatory Bowel Disease Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Inflammatory Bowel Disease Market Share (2018-2019)
Table Southeast Asia Inflammatory Bowel Disease Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Inflammatory Bowel Disease Market Share by Type (2014-2019)
Table Southeast Asia Inflammatory Bowel Disease Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Inflammatory Bowel Disease Market Share by Application (2014-2019)
Figure India Inflammatory Bowel Disease Market Size 2014-2019 (Million US$)
Table India Key Players Inflammatory Bowel Disease Revenue (2018-2019) (Million US$)
Table India Key Players Inflammatory Bowel Disease Market Share (2018-2019)
Table India Inflammatory Bowel Disease Market Size by Type (2014-2019) (Million US$)
Table India Inflammatory Bowel Disease Market Share by Type (2014-2019)
Table India Inflammatory Bowel Disease Market Size by Application (2014-2019) (Million US$)
Table India Inflammatory Bowel Disease Market Share by Application (2014-2019)
Figure Central & South America Inflammatory Bowel Disease Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Inflammatory Bowel Disease Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Inflammatory Bowel Disease Market Share (2018-2019)
Table Central & South America Inflammatory Bowel Disease Market Size by Type (2014-2019) (Million US$)
Table Central & South America Inflammatory Bowel Disease Market Share by Type (2014-2019)
Table Central & South America Inflammatory Bowel Disease Market Size by Application (2014-2019) (Million US$)
Table Central & South America Inflammatory Bowel Disease Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Inflammatory Bowel Disease Business (2014-2019) (Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Inflammatory Bowel Disease Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Baxter International Company Details
Table Baxter International Revenue in Inflammatory Bowel Disease Business (2014-2019)(Million US$)
Figure Baxter International Revenue Growth Rate in Inflammatory Bowel Disease Business (2014-2019)
Table Baxter International Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Inflammatory Bowel Disease Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Sanofi-Aventis Company Details
Table Sanofi-Aventis Revenue in Inflammatory Bowel Disease Business (2014-2019)(Million US$)
Figure Sanofi-Aventis Revenue Growth Rate in Inflammatory Bowel Disease Business (2014-2019)
Table Sanofi-Aventis Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Inflammatory Bowel Disease Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Inflammatory Bowel Disease Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Pluristem Therapeutics Company Details
Table Pluristem Therapeutics Revenue in Inflammatory Bowel Disease Business (2014-2019)(Million US$)
Figure Pluristem Therapeutics Revenue Growth Rate in Inflammatory Bowel Disease Business (2014-2019)
Table Pluristem Therapeutics Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Inflammatory Bowel Disease Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Inflammatory Bowel Disease Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Inflammatory Bowel Disease Business (2014-2019)
Table AstraZeneca Recent Development
Table Cephalon Company Details
Table Cephalon Revenue in Inflammatory Bowel Disease Business (2014-2019)(Million US$)
Figure Cephalon Revenue Growth Rate in Inflammatory Bowel Disease Business (2014-2019)
Table Cephalon Recent Development
Table Amgen Company Details
Table Amgen Revenue in Inflammatory Bowel Disease Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Inflammatory Bowel Disease Business (2014-2019)
Table Amgen Recent Development
Table Global Inflammatory Bowel Disease Market Size by Regions (Million US$) 2019-2025
Figure Global Inflammatory Bowel Disease Market Size Share by Regions (2019-2025)
Figure Global Inflammatory Bowel Disease Market Size Share by Regions in 2025
Figure United States Inflammatory Bowel Disease Market Size Forecast (2019-2025)(Million USD)
Figure Europe Inflammatory Bowel Disease Market Size Forecast (2019-2025)(Million USD)
Figure China Inflammatory Bowel Disease Market Size Forecast (2019-2025)(Million USD)
Figure Japan Inflammatory Bowel Disease Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Inflammatory Bowel Disease Market Size Forecast (2019-2025)(Million USD)
Figure India Inflammatory Bowel Disease Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Inflammatory Bowel Disease Market Size Forecast (2019-2025)(Million USD)
Table Global Inflammatory Bowel Disease Market Size by Product (2019-2025) (Million US$)
Figure Global Inflammatory Bowel Disease Market Size by Product (2019-2025)
Figure Global Inflammatory Bowel Disease Market Size by Product in 2025
Table Global Inflammatory Bowel Disease Market Size by Application (2019-2025) (Million US$)
Figure Global Inflammatory Bowel Disease Market Size by Application (2019-2025)
Figure Global Inflammatory Bowel Disease Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
炎症性腸疾患薬の世界市場：インサイト・予測 Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease. The growth in prevalence of inflammatory bowel diseases such as ulcerative …- 腸疾患の検査および治療の世界市場：市場規模・現状・予測 Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases. Ac…
- 短腸症候群（SBS）の世界市場：市場規模・現状・予測 Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 短腸症候群（SBS）治療薬の世界市場：市場規模・現状・予測 Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 感染症検査における分子診断の世界市場：市場規模・現状・予測 Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …